Pay in 4 interest-free payments of $5.49 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Once-weekly injection Brand-name semaglutide FDA-approved for weight management Provider-reviewed before prescribed $1,199/mo Includes your provider consult and the medication, shipped to you
Breaking Plateaus For patients who have stalled on other therapies, the triple-agonist mechanism provides a new metabolic stimulus to support further provider-guided evaluation after a plateau
Empower in a statement said restricting access to personalized alternatives to commercial drugs is not in the best interest of patients, and it's "committed to offering these life-changing formulations." Strive called Lilly's lawsuit a classic example of Big Pharma overstepping legitimate regulations to prioritize its own interests and said it will vigorously defend its position
It's your own biology, amplified and delivered exactly where your body needs it most
In reality, there are several reasons why results often take time
Choose Tirzepatide if you want: The highest documented long-term weight loss Extensive global safety data A treatment available outside China Strong diabetes and cardiovascular benefits Choose Mazdutide if you want: Dramatic improvement in liver fat reduction Better metabolic benefits for Asian body profiles Added fat-burning from increased energy expenditure Access within China where it is approved Both medications represent a major leap forward in obesity and metabolic disease careand ongoing research will continue shaping how each is used across different populations
US$ 29.45
US$ 25.33
US$ 28.14
US$ 26.48
US$ 20.61
US$ 22.42
